NDC 50222-227

Taclonex

Calcipotriene And Betamethasone Dipropionate

Taclonex is a Topical Ointment in the Human Prescription Drug category. It is labeled and distributed by Leo Pharma Inc.. The primary component is Calcipotriene Hydrate; Betamethasone Dipropionate.

Product ID50222-227_1848162c-3861-452d-ab17-5098b816834a
NDC50222-227
Product TypeHuman Prescription Drug
Proprietary NameTaclonex
Generic NameCalcipotriene And Betamethasone Dipropionate
Dosage FormOintment
Route of AdministrationTOPICAL
Marketing Start Date2008-06-01
Marketing CategoryNDA / NDA
Application NumberNDA021852
Labeler NameLEO Pharma Inc.
Substance NameCALCIPOTRIENE HYDRATE; BETAMETHASONE DIPROPIONATE
Active Ingredient Strength50 ug/g; mg/g
Pharm ClassesVitamin D [CS],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50222-227-04

1 TUBE in 1 CARTON (50222-227-04) > 60 g in 1 TUBE
Marketing Start Date2008-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50222-227-07 [50222022707]

Taclonex OINTMENT
Marketing CategoryNDA
Application NumberNDA021852
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-06-01
Marketing End Date2016-01-25

NDC 50222-227-04 [50222022704]

Taclonex OINTMENT
Marketing CategoryNDA
Application NumberNDA021852
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2008-06-01

NDC 50222-227-81 [50222022781]

Taclonex OINTMENT
Marketing CategoryNDA
Application NumberNDA021852
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2008-06-01

Drug Details

Active Ingredients

IngredientStrength
CALCIPOTRIENE HYDRATE50 ug/g

OpenFDA Data

SPL SET ID:ef43ba2d-20ce-4415-b5c2-e486b836812e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 388525
  • 833472

    • Pharmacological Class

    • Vitamin D [CS]
    • Vitamin D Analog [EPC]
    • Corticosteroid [EPC]
    • Corticosteroid Hormone Receptor Agonists [MoA]

    Medicade Reported Pricing

    50222022781 TACLONEX OINTMENT

    Pricing Unit: GM | Drug Type:

    50222022704 TACLONEX OINTMENT

    Pricing Unit: GM | Drug Type:

    NDC Crossover Matching brand name "Taclonex" or generic name "Calcipotriene And Betamethasone Dipropionate"

    NDCBrand NameGeneric Name
    50222-227Taclonexcalcipotriene and betamethasone dipropionate
    50222-501TACLONEXcalcipotriene and betamethasone dipropionate
    0781-7165CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATEcalcipotriene and betamethasone dipropionate
    45802-889calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    45802-989Calcipotriene and Betamethasone Dipropionatecalcipotriene and betamethasone dipropionate
    51672-1402Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
    63629-8618calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    63629-8619calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    63646-040calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    66993-937Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
    66993-938Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
    50222-302ENSTILARcalcipotriene and betamethasone dipropionate
    73499-001WynzoraCalcipotriene and Betamethasone dipropionate

    Trademark Results [Taclonex]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TACLONEX
    TACLONEX
    76527083 3022407 Live/Registered
    LEO Pharma A/S
    2003-07-01
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.